ACE-2 Inhibitor Screening Assay Kit
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-24468
Key Product Details
Kit Type
Inhibitor Screening Assay Kit
Product Summary for ACE-2 Inhibitor Screening Assay Kit
Detection instrument: Fluorescence microplate reader (Ex/Em = 325 nm/395 nm)
Assay time: 45 min
Assay time: 45 min
Scientific Data Images for ACE-2 Inhibitor Screening Assay Kit
ACE-2 Inhibitor Screening Assay Kit [NBP3-24468] -
ACE-2 Inhibitor Screening Assay Kit [NBP3-24468] - Standard Reference CurveACE-2 Inhibitor Screening Assay Kit [NBP3-24468] -
ACE-2 Inhibitor Screening Assay Kit [NBP3-24468] - Assay ExampleKit Contents for ACE-2 Inhibitor Screening Assay Kit
- Black Microplate
- Plate Sealer
- Reagent 1: Buffer Solution
- Reagent 2: Enzyme Reagent
- Reagent 3: Substrate
- Reagent 4: Inhibitors
Formulation, Preparation, and Storage
Concentration
Concentration is not relevant for this product. Please see the protocols for proper use of this product.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Storage of components varies. See protocol for specific instructions.
Background: ACE-2
Genetic data from Drosophila, mice and rats show that the ACE2 protein is an essential regulator of heart function in vivo. ACE2 mRNA is found at high levels in testis, kidney and heart with moderate levels in colon, small intestine, and ovary. The ACE2 protein contributes to organ function through the renin-angiotensin system, playing a central role in vascular, renal, and myocardial physiology.
Virology research has demonstrated that the severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein binds to its functional receptor, ACE2 (1). Vimentin is a type III intermediate filament protein expressed in mesenchymal cells that helps comprise the cytoskeleton in all animal cells. Studies have demonstrated that vimentin allows cell binding that allows the uptake of SARS-CoV spike protein into a host (2). This direct interaction of SARS-CoV with vimentin has been identified as an entry mechanism for the virus into a host, mediated by the SARS-CoV receptor ACE2 (1,2). It has been shown that ACE2 is the SARS-CoV-2 receptor required for cell entry and plays a physiological role in the replication of SARS-CoV in an infected host (1). Studies using human ACE2 antibody demonstrated a blockade of SARS-CoV-2 and ACE2 interaction, indicating an important physiological component of viral transmission and potential anti-viral therapeutic strategies (3).
References
1. Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., . . . Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 426(6965), 450-454. doi:10.1038/nature02145
2. Yu YT, Chien SC, Chen IY, Lai CT, Tsay YG, Chang SC, Chang MF. (2016) Surface vimentin is critical for the cell entry of SARS-CoV. J Biomed Sci. doi: 10.1186/s12929-016-0234-7
3. Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kruger, N., Herrler, T., Erichsen, S., . . . Pohlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. doi:10.1016/j.cell.2020.02.052
Long Name
Angiotensin I Converting Enzyme 2
Alternate Names
ACE2, ACEH
Gene Symbol
ACE2
Additional ACE-2 Products
Product Documents for ACE-2 Inhibitor Screening Assay Kit
Product Specific Notices for ACE-2 Inhibitor Screening Assay Kit
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...